Guided Therapeutics Inc (GTHP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 22 | 0 | 3 | 5 | 5 |
| Cost of Goods | 9 | 79 | 0 | 1 | 1 |
| Gross Profit | 13 | -79 | 3 | 4 | 4 |
| Operating Expenses | 865 | 949 | 1,227 | 722 | 448 |
| Operating Income | -843 | -949 | -1,224 | -717 | -443 |
| Interest Expense | 66 | 70 | 155 | 256 | 101 |
| Other Income | 40 | -787 | 277 | 47 | 37 |
| Pre-tax Income | -869 | -1,806 | -1,102 | -926 | -507 |
| Net Income Continuous | -869 | -1,806 | -1,102 | -926 | -507 |
| Net Income | $-869 | $-1,806 | $-1,102 | $-926 | $-507 |
| EPS Basic Total Ops | -0.02 | -0.03 | -0.03 | -0.04 | -0.05 |
| EPS Basic Continuous Ops | -0.02 | -0.04 | -0.03 | -0.04 | -0.02 |
| EPS Diluted Total Ops | -0.02 | -0.03 | -0.03 | -0.04 | -0.05 |
| EPS Diluted Continuous Ops | -0.02 | -0.04 | -0.03 | -0.04 | -0.02 |
| EBITDA(a) | $-791 | $-896 | $-1,173 | $-663 | $-386 |